{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:54:12Z","timestamp":1792090452066,"version":"4.4.0"},"reference-count":115,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T00:00:00Z","timestamp":1647993600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.fertnstert.2022.03.008","type":"journal-article","created":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T21:15:13Z","timestamp":1651785313000},"page":"887-896","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Cardiometabolic biomarkers in women with polycystic ovary syndrome"],"prefix":"10.1016","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3401-4585","authenticated-orcid":false,"given":"Kim","family":"van der Ham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne V.","family":"Louwers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5444-9845","authenticated-orcid":false,"given":"Joop S.E.","family":"Laven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2022.03.008_bib1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","article-title":"Criteria, prevalence, and phenotypes of polycystic ovary syndrome","volume":"106","author":"Lizneva","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0002-9378(15)30642-6","article-title":"Amenorrhea associated with bilateral polycystic ovaries","volume":"29","author":"Stein","year":"1935","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib4","doi-asserted-by":"crossref","first-page":"16057","DOI":"10.1038\/nrdp.2016.57","article-title":"Polycystic ovary syndrome","volume":"2","author":"Azziz","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/1358863X16682107","article-title":"Obese adolescents with polycystic ovarian syndrome have elevated cardiovascular disease risk markers","volume":"22","author":"Patel","year":"2017","journal-title":"Vasc Med"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/09513590.2017.1359250","article-title":"Polycystic ovary syndrome among obese adolescents","volume":"34","author":"Ybarra","year":"2018","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib7","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00404-020-05867-x","article-title":"Comparison of metabolic and obesity biomarkers between adolescent and adult women with polycystic ovary syndrome","volume":"303","author":"de Medeiros","year":"2021","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib8","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1210\/jc.2012-3537","article-title":"Prevalence of hyperandrogenic states in late adolescent and young women: epidemiological survey on Italian high-school students","volume":"98","author":"Gambineri","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib9","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.dsx.2018.03.014","article-title":"Risk of metabolic syndrome in adolescents with polycystic ovarian syndrome: a systematic review and meta-analysis","volume":"12","author":"Fazleen","year":"2018","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib10","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1210\/jc.2005-1852","article-title":"The association of obesity and hyperandrogenemia during the pubertal transition in girls: obesity as a potential factor in the genesis of postpubertal hyperandrogenism","volume":"91","author":"McCartney","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib11","first-page":"291","article-title":"Features of polycystic ovary syndrome in adolescence","volume":"8","author":"Tsikouras","year":"2015","journal-title":"J Med Life"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib12","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1196\/annals.1429.005","article-title":"Polycystic ovary syndrome in adolescence","volume":"1135","author":"Blank","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib13","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/pedi.13206","article-title":"Development of type 2 diabetes in adolescent girls with polycystic ovary syndrome and obesity","volume":"22","author":"Hudnut-Beumler","year":"2021","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib14","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1080\/01443615.2017.1318840","article-title":"Metabolic effect of obesity on polycystic ovary syndrome in adolescents: a meta-analysis","volume":"37","author":"Li","year":"2017","journal-title":"J Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jpag.2014.08.011","article-title":"What is the risk of metabolic syndrome in adolescents with normal BMI who have polycystic ovary syndrome?","volume":"28","author":"Aydin","year":"2015","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib16","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.steroids.2011.12.003","article-title":"Inflammation in polycystic ovary syndrome: underpinning of insulin resistance and ovarian dysfunction","volume":"77","author":"Gonz\u00e1lez","year":"2012","journal-title":"Steroids"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib17","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00404-020-05951-2","article-title":"Association of metabolic and inflammatory markers with polycystic ovarian syndrome (PCOS): an update","volume":"303","author":"Abraham Gnanadass","year":"2021","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib18","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.fertnstert.2014.05.032","article-title":"Insulin resistance and its relationship with high molecular weight adiponectin in adolescents with polycystic ovary syndrome and a maternal history of polycystic ovary syndrome","volume":"102","author":"Cankaya","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib19","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/389317","article-title":"IL-6 serum levels and production is related to an altered immune response in polycystic ovary syndrome girls with insulin resistance","volume":"2011","author":"Fulghesu","year":"2011","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib20","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1399-5448.2007.00271.x","article-title":"The metabolic syndrome in children and adolescents - an IDF consensus report","volume":"8","author":"Zimmet","year":"2007","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib21","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1749-6632.2000.tb06230.x","article-title":"The genetics of obesity. Lessons for polycystic ovary syndrome","volume":"900","author":"Legro","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib22","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1093\/oxfordjournals.humrep.a136243","article-title":"Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients","volume":"10","author":"Balen","year":"1995","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib23","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/719050","article-title":"Polycystic ovary syndrome, insulin resistance, and obesity: navigating the pathophysiologic labyrinth","volume":"2014","author":"Rojas","year":"2014","journal-title":"Int J Reprod Med"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib24","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/humupd\/dms030","article-title":"Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"18","author":"Lim","year":"2012","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/humrep\/dem356","article-title":"Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome","volume":"23","author":"Cascella","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib26","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/aogs.12964","article-title":"Comparison of regional fat mass measurement by whole body DXA scans and anthropometric measures to predict insulin resistance in women with polycystic ovary syndrome and controls","volume":"95","author":"Glintborg","year":"2016","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.697223","article-title":"Imaging-based body fat distribution in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"12","author":"Zhu","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib28","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/j.1471-0528.2006.00973.x","article-title":"The central issue? Visceral fat mass is a good marker of insulin resistance and metabolic disturbance in women with polycystic ovary syndrome","volume":"113","author":"Lord","year":"2006","journal-title":"BJOG"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib29","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1093\/humrep\/dew243","article-title":"Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic-hyperinsulinaemic clamp studies","volume":"31","author":"Cassar","year":"2016","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib30","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/humupd\/dmaa029","article-title":"Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis","volume":"26","author":"Wekker","year":"2020","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib31","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/humupd\/dmy007","article-title":"Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression","volume":"24","author":"Kakoly","year":"2018","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib32","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.jogc.2018.11.026","article-title":"Comprehensive evaluation of type 2 diabetes and cardiovascular disease risk profiles in reproductive-age women with polycystic ovary syndrome: a large Canadian cohort","volume":"41","author":"Kazemi","year":"2019","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib33","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1093\/humrep\/dev195","article-title":"Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features","volume":"30","author":"Daan","year":"2015","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib34","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.fertnstert.2016.12.017","article-title":"Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life","volume":"107","author":"Pinola","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib35","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.fertnstert.2014.08.001","article-title":"Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk?","volume":"102","author":"Daan","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib36","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.fertnstert.2010.12.027","article-title":"Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis","volume":"95","author":"Wild","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib37","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1210\/jc.2007-1756","article-title":"A more atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome: a case-control study","volume":"93","author":"Valkenburg","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0164021","article-title":"High serum tumor necrosis factor-alpha levels in women with polycystic ovary syndrome: a meta-analysis","volume":"11","author":"Gao","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib39","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.fertnstert.2010.11.036","article-title":"Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis","volume":"95","author":"Escobar-Morreale","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib40","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1089\/met.2006.4.122","article-title":"Association between circulating tumor necrosis factor-alpha, interleukin-6, and insulin resistance in normal-weight women with polycystic ovary syndrome","volume":"4","author":"Tarkun","year":"2006","journal-title":"Metab Syndr Relat Disord"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2020.103155","article-title":"Role of IL-6 signalling in polycystic ovarian syndrome associated inflammation","volume":"141","author":"Borthakur","year":"2020","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib42","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/27376","article-title":"Leptin and the regulation of body weight in mammals","volume":"395","author":"Friedman","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib43","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.atherosclerosis.2006.03.003","article-title":"Leptin and atherosclerosis","volume":"189","author":"Beltowski","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib44","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/aps.2018.40","article-title":"Leptin, cardiovascular diseases and type 2 diabetes mellitus","volume":"39","author":"Katsiki","year":"2018","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib45","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00404-017-4429-2","article-title":"Polycystic ovary syndrome, adipose tissue and metabolic syndrome","volume":"296","author":"Delitala","year":"2017","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib46","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1161\/01.ATV.0000099786.99623.EF","article-title":"Adiponectin and metabolic syndrome","volume":"24","author":"Matsuzawa","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib47","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0006-291X(03)00090-1","article-title":"Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes","volume":"301","author":"Fasshauer","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib48","doi-asserted-by":"crossref","first-page":"E527","DOI":"10.1152\/ajpendo.00110.2003","article-title":"Regulation of adiponectin by adipose tissue-derived cytokines: in\u00a0vivo and in\u00a0vitro investigations in humans","volume":"285","author":"Bruun","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib49","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1007\/s13277-013-1595-0","article-title":"Low circulating adiponectin levels in women with polycystic ovary syndrome: an updated meta-analysis","volume":"35","author":"Li","year":"2014","journal-title":"Tumour Biol"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib50","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1365-2265.2004.02159.x","article-title":"Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome","volume":"61","author":"Spranger","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib51","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1530\/EJE-10-0021","article-title":"Distribution of adiponectin multimeric forms in Chinese women with polycystic ovary syndrome and their relation to insulin resistance","volume":"163","author":"Tao","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib52","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.metabol.2010.02.019","article-title":"Total and high-molecular weight adiponectin in women with the polycystic ovary syndrome","volume":"60","author":"Wickham","year":"2011","journal-title":"Metabolism"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib53","doi-asserted-by":"crossref","first-page":"21758","DOI":"10.1002\/jcp.28913","article-title":"Implications of resistin in type 2 diabetes mellitus and coronary artery disease: impairing insulin function and inducing pro-inflammatory cytokines","volume":"234","author":"Emamalipour","year":"2019","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib54","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/humupd\/dmv058","article-title":"Activins in reproductive biology and beyond","volume":"22","author":"Wijayarathna","year":"2016","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib55","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/dmrr.2415","article-title":"Plasma follistatin is elevated in patients with type 2 diabetes: relationship to hyperglycemia, hyperinsulinemia, and systemic low-grade inflammation","volume":"29","author":"Hansen","year":"2013","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0246200","article-title":"Circulating resistin and follistatin levels in obese and non-obese women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"16","author":"Raeisi","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib57","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.2337\/db06-0259","article-title":"Serum visfatin increases with progressive beta-cell deterioration","volume":"55","author":"L\u00f3pez-Bermejo","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib58","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.jstrokecerebrovasdis.2009.01.003","article-title":"Elevated visfatin\/pre-B-cell colony-enhancing factor plasma concentration in ischemic stroke","volume":"18","author":"Lu","year":"2009","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib59","doi-asserted-by":"crossref","first-page":"808","DOI":"10.3109\/09513590.2015.1056140","article-title":"High-visfatin levels in women with polycystic ovary syndrome: evidence from a meta-analysis","volume":"31","author":"Sun","year":"2015","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib60","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1177\/1933719116653681","article-title":"Overexpression of IL-18 in the proliferative phase endometrium of patients with polycystic ovary syndrome","volume":"24","author":"Long","year":"2017","journal-title":"Reprod Sci"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib61","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1080\/09513590.2017.1395835","article-title":"The relationship between IL-18 and atherosclerotic cardiovascular risk in Egyptian lean women with polycystic ovary syndrome","volume":"34","author":"Dawood","year":"2018","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib62","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/758656","article-title":"Mediators of inflammation in polycystic ovary syndrome in relation to adiposity","volume":"2010","author":"Sathyapalan","year":"2010","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib63","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1210\/jc.2015-4275","article-title":"Enhanced inflammatory transcriptome in the granulosa cells of women with polycystic ovarian syndrome","volume":"101","author":"Adams","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib64","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/molehr\/gat051","article-title":"Differential expression of inflammation-related genes in the ovarian stroma and granulosa cells of PCOS women","volume":"20","author":"Schmidt","year":"2014","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib65","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1080\/09513590.2017.1371691","article-title":"Evaluation of pro-oxidant-antioxidant balance (PAB) and its association with inflammatory cytokines in polycystic ovary syndrome (PCOS)","volume":"34","author":"Artimani","year":"2018","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib66","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1530\/JOE-19-0297","article-title":"Elucidating the role of pigment epithelium-derived factor (PEDF) in metabolic PCOS models","volume":"244","author":"Silber","year":"2020","journal-title":"J Endocrinol"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib67","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.mgene.2016.08.001","article-title":"Interleukin 10 (-1082 G\/A) and (-819 C\/T) gene polymorphisms in Egyptian women with polycystic ovary syndrome (PCOS)","volume":"9","author":"Talaat","year":"2016","journal-title":"Meta Gene"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib68","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1744-313X.2007.00746.x","article-title":"Polymorphism of the interleukin-10 gene in polycystic ovary syndrome","volume":"35","author":"Karadeniz","year":"2008","journal-title":"Int J Immunogenet"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib69","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrendo.2018.24","article-title":"Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment","volume":"14","author":"Escobar-Morreale","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib70","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/09513590701554306","article-title":"Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome","volume":"23","author":"Guzelmeric","year":"2007","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib71","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1093\/humrep\/del003","article-title":"Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin","volume":"21","author":"Diamanti-Kandarakis","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib72","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.yjmcc.2008.06.003","article-title":"CCL3 (MIP-1 alpha) levels are elevated during acute coronary syndromes and show strong prognostic power for future ischemic events","volume":"45","author":"de Jager","year":"2008","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib73","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1042\/CS20080581","article-title":"Role of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implications","volume":"117","author":"Niu","year":"2009","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib74","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1365-2265.2009.03523.x","article-title":"Plasma monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1alpha are increased in patients with polycystic ovary syndrome (PCOS) and associated with adiposity, but unaffected by pioglitazone treatment","volume":"71","author":"Glintborg","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib75","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.metabol.2009.02.022","article-title":"Evidence of proatherogenic inflammation in polycystic ovary syndrome","volume":"58","author":"Gonz\u00e1lez","year":"2009","journal-title":"Metabolism"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib76","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1161\/CIRCULATIONAHA.106.621854","article-title":"Advanced glycation end products: sparking the development of diabetic vascular injury","volume":"114","author":"Goldin","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib77","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1365-2265.2008.03247.x","article-title":"Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS)","volume":"69","author":"Diamanti-Kandarakis","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib78","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.metabol.2015.08.010","article-title":"Advanced glycation end products: a link between metabolic and endothelial dysfunction in polycystic ovary syndrome?","volume":"64","author":"Pertynska-Marczewska","year":"2015","journal-title":"Metabolism"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib79","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/obr.12762","article-title":"Metabolic syndrome in polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression","volume":"20","author":"Lim","year":"2019","journal-title":"Obes Rev"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib80","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.dsx.2019.01.002","article-title":"The association between metabolic syndrome and polycystic ovary syndrome: a systematic review and meta-analysis","volume":"13","author":"Otaghi","year":"2019","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib81","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/cen.13477","article-title":"The risk of metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"88","author":"Behboudi-Gandevani","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib82","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ajog.2019.04.023","article-title":"Fat mass changes during menopause: a metaanalysis","volume":"221","author":"Ambikairajah","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib83","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/cen.14117","article-title":"The cardiovascular risk profile of middle-aged women with polycystic ovary syndrome","volume":"92","author":"Meun","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib84","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1046\/j.1365-2265.2000.01000.x","article-title":"Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study","volume":"52","author":"Wild","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib85","doi-asserted-by":"crossref","first-page":"E868","DOI":"10.1210\/jc.2011-3357","article-title":"Relative contributions of oligomenorrhea and hyperandrogenemia to the risk of metabolic syndrome in midlife women","volume":"97","author":"Polotsky","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib86","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1210\/jc.2017-02421","article-title":"High androgens in postmenopausal women and the risk for atherosclerosis and cardiovascular disease: the Rotterdam study","volume":"103","author":"Meun","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib87","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/cen.14647","article-title":"Natural history of polycystic ovary syndrome: a systematic review of cardiometabolic outcomes from longitudinal cohort studies","volume":"96","author":"Kiconco","year":"2022","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib88","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1210\/jc.2011-1677","article-title":"Cardiovascular disease and risk factors in PCOS women of postmenopausal age: a 21-year controlled follow-up study","volume":"96","author":"Schmidt","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib89","article-title":"Characteristics of polycystic ovary syndrome throughout life","volume":"14","author":"Louwers","year":"2020","journal-title":"Ther Adv Reprod Health"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib90","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1464-5491.2007.02157.x","article-title":"International Diabetes Federation: a consensus on type 2 diabetes prevention","volume":"24","author":"Alberti","year":"2007","journal-title":"Diabet Med"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib91","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1001\/jama.2021.12531","article-title":"Screening for prediabetes and type 2 diabetes: US Preventive Services Task Force Recommendation Statement","volume":"326","author":"Davidson","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib92","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.2337\/db11-1360","article-title":"Polycystic ovary syndrome is a risk factor for type 2 diabetes: results from a long-term prospective study","volume":"61","author":"Gambineri","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib93","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1089\/jwh.2015.5441","article-title":"Cardiovascular disease and 10-year mortality in postmenopausal women with clinical features of polycystic ovary syndrome","volume":"25","author":"Merz","year":"2016","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib94","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/AOG.0b013e31820209bb","article-title":"Polycystic ovary syndrome and risk for long-term diabetes and dyslipidemia","volume":"117","author":"Wang","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib95","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0889-8561(02)00056-5","article-title":"Age-related inflammatory cytokines and disease","volume":"23","author":"Br\u00fc\u00fcnsgaard","year":"2003","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib96","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/humupd\/dmv029","article-title":"Pregnancy complications in women with polycystic ovary syndrome","volume":"21","author":"Palomba","year":"2015","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib97","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.fertnstert.2016.09.042","article-title":"Endocrine and cardiometabolic cord blood characteristics of offspring born to mothers with and without polycystic ovary syndrome","volume":"107","author":"Daan","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib98","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1210\/jc.2009-2651","article-title":"Infants of women with polycystic ovary syndrome have lower cord blood androstenedione and estradiol levels","volume":"95","author":"Anderson","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib99","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/humupd\/dmz036","article-title":"Cardiometabolic health in offspring of women with PCOS compared to healthy controls: a systematic review and individual participant data meta-analysis","volume":"26","author":"Gunning","year":"2020","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib100","doi-asserted-by":"crossref","first-page":"S869","DOI":"10.1016\/j.ajog.2017.12.012","article-title":"Long-term cardiovascular consequences of fetal growth restriction: biology, clinical implications, and opportunities for prevention of adult disease","volume":"218","author":"Crispi","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib101","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1080\/09513590.2018.1563885","article-title":"Associations of preconception body mass index in women with PCOS and BMI and blood pressure of their offspring","volume":"35","author":"Gunning","year":"2019","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib102","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1210\/jc.2007-2256","article-title":"Metabolic profile in sons of women with polycystic ovary syndrome","volume":"93","author":"Recabarren","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib103","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.fertnstert.2017.10.018","article-title":"Metabolic syndrome, hypertension, and hyperlipidemia in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"109","author":"Yilmaz","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib104","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.fertnstert.2011.09.002","article-title":"The phenotype of polycystic ovary syndrome ameliorates with aging","volume":"96","author":"Brown","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib105","first-page":"1","article-title":"2000 CDC growth charts for the United States: methods and development","volume":"11","author":"Kuczmarski","year":"2002","journal-title":"Vital Health Stat"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib106","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/oby.2002.108","article-title":"Assessing the validity of body mass index standards in early postmenopausal women","volume":"10","author":"Blew","year":"2002","journal-title":"Obes Res"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib107","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/GME.0000000000000989","article-title":"Is BMI a valid measure of obesity in postmenopausal women?","volume":"25","author":"Banack","year":"2018","journal-title":"Menopause"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib108","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jpeds.2004.06.044","article-title":"Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents","volume":"145","author":"Fern\u00e1ndez","year":"2004","journal-title":"J Pediatr"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib109","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/aje\/kwr093","article-title":"Optimal cutoff values for high-risk waist circumference in older adults based on related health outcomes","volume":"174","author":"Heim","year":"2011","journal-title":"Am J Epidemiol"},{"issue":"Suppl 2","key":"10.1016\/j.fertnstert.2022.03.008_bib110","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1038\/ijo.2014.134","article-title":"Percentiles of fasting serum insulin, glucose, HbA1c and HOMA-IR in pre-pubertal normal weight European children from the IDEFICS cohort","volume":"38","author":"Peplies","year":"2014","journal-title":"Int J Obes (Lond)"},{"issue":"Suppl 5","key":"10.1016\/j.fertnstert.2022.03.008_bib111","first-page":"S213","volume":"128","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib112","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib113","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-1904","article-title":"Clinical practice guideline for screening and management of high blood pressure in children and adolescents","volume":"140","author":"Flynn","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib114","first-page":"e484","volume":"138","author":"Whelton","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.fertnstert.2022.03.008_bib115","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.fertnstert.2018.05.004","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"110","author":"Teede","year":"2018","journal-title":"Fertil Steril"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028222001923?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028222001923?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T08:34:25Z","timestamp":1758011665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028222001923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":115,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0015028222001923"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2022.03.008","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiometabolic biomarkers in women with polycystic ovary syndrome","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2022.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92022 The Authors. Published by Elsevier Inc. on behalf of the American Society for Reproductive Medicine.","name":"copyright","label":"Copyright"}]}}